Karen L. Zaderej
CIK 1530968 · CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$48.64M
Companies
3
Total Filings
75
Lifetime Open-Market Net
-$2.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 6 of 8
75 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-19 | AXGN | Grant (A) | +16,015 | $281.4K | EDGAR |
| 2019-01-02 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +9,524 | $0 | EDGAR |
| 2018-12-31 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2018-12-21 | AXGN | Exer (M) | +30,000 | $82.2K | EDGAR |
| 2018-11-21 | AXGN | Mixed | +63,239 | -$10 | EDGAR |
| 2018-11-15 | AXGN | Sell (S) | −25,000 | -$829.6K | EDGAR |
| 2018-10-04 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +746 | $0 | EDGAR |
| 2018-09-14 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-09 | AXGN | Tax (F) | −10,060 | -$395.4K | EDGAR |
| 2018-08-06 | AXGN | Exer (M) | +175,000 | $479.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.